PharmaSUG2016paper·US·Beyond the BasicsSuperior Highlighting: Identifying New or Changed Data in Excel Output using SAS® BB06See metadata
PharmaSUG2016paper·US·Beyond the BasicsMeaningful Presentation of Clinical Trial Data with Multiple Y-Axes Graph BB07See metadata
PharmaSUG2016paper·US·Beyond the BasicsNovel Programming Methods for Change from Baseline Calculations BB08See metadata
PharmaSUG2016paper·US·Beyond the BasicsName that Function: Punny Function Names with Multiple MEANings and Why You Do Not Want to be MISSING Out BB10See metadata
PharmaSUG2016paper·US·Beyond the BasicsSurviving the SAS® Macro Jungle by Using Your Own Programming Toolkit BB11See metadata
PharmaSUG2016paper·US·Beyond the BasicsPreparing the Data to Ensure Correct Calculation of Relative Risk BB12See metadata
PharmaSUG2016paper·US·Beyond the BasicsThe Power of Data Access Functions: An example with Dataset-XML Creation BB13See metadata
PharmaSUG2016paper·US·Beyond the BasicsMacro to get data from specific cutoff period BB14See metadata
PharmaSUG2016paper·US·Beyond the BasicsThe Impact of Change from wlatin1 to UTF-8 Encoding in SAS Environment BB15See metadata
PharmaSUG2016paper·US·Beyond the BasicsUTF What? A Guide to Using UTF-8 Encoded Data in a SDTM Submission BB16See metadata
PharmaSUG2016paper·China·CDISCPractical Experience in Implementing CDISC Standards for Global Cardiovascular, Clinical Outcome Assessment and Respiratory Trials CD-01 BeijingSee metadata
PharmaSUG2016paper·China·CDISCFrom Data Collection to Regulatory Submission - a Journey CD-02 BeijingSee metadata
PharmaSUG2016paper·China·CDISCThe Dream of a Common Vision: (Evolving) Standards CD-03 BeijingSee metadata
PharmaSUG2016paper·China·CDISCADaM Compliance VS Easy-Reviewed in Design and Construct Efficacy Analysis Datasets CD-05 BeijingSee metadata
PharmaSUG2016paper·China·CDISCHow to handle the mapping of the eCRF form with the combined information CD-06 BeijingSee metadata
PharmaSUG2016paper·China·CDISCAnalysis of Patient Reported Outcome (PRO) Endpoints in Clinical Trial CD-07 BeijingSee metadata
PharmaSUG2016paper·China·CDISCDevelopment Approach on the Sponsor-Defined Extensions of the Model CD-08 BeijingSee metadata
PharmaSUG2016paper·China·CDISCStrategy to Start to Implement CDISC Standards CD-09 BeijingSee metadata